Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

J. A. Sparano; L. J. Brandt; J. P. Dutcher; J. S. DuBois; M. B. Atkins

doi:10.7326/0003-4819-118-8-199304150-00007

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

J. A. Sparano, L. J. Brandt, J. P. Dutcher, J. S. DuBois, M. B. Atkins

Medicine

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

Original language	English (US)
Pages (from-to)	617-618
Number of pages	2
Journal	Annals of internal medicine
Volume	118
Issue number	8
DOIs	https://doi.org/10.7326/0003-4819-118-8-199304150-00007
State	Published - 1993

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/0003-4819-118-8-199304150-00007

Cite this

@article{0af0890458f64c518b95758fb68c98ce,

title = "Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2",

abstract = "Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.",

author = "Sparano, {J. A.} and Brandt, {L. J.} and Dutcher, {J. P.} and DuBois, {J. S.} and Atkins, {M. B.}",

year = "1993",

doi = "10.7326/0003-4819-118-8-199304150-00007",

language = "English (US)",

volume = "118",

pages = "617--618",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

AU - Sparano, J. A.

AU - Brandt, L. J.

AU - Dutcher, J. P.

AU - DuBois, J. S.

AU - Atkins, M. B.

PY - 1993

Y1 - 1993

N2 - Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

AB - Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

UR - http://www.scopus.com/inward/record.url?scp=0027419329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027419329&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-118-8-199304150-00007

DO - 10.7326/0003-4819-118-8-199304150-00007

M3 - Article

C2 - 8452327

AN - SCOPUS:0027419329

SN - 0003-4819

VL - 118

SP - 617

EP - 618

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 8

ER -

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this